Market News
Global General Surgery Devices Market- Recent Developments
Product Launch
- On February 7, 2023, OSSIO, Inc., a fast-growing orthopedic fixation technology company, announced the launch of the new OSSIOfiber Compression Staple, the next step towards becoming the gold standard in orthopedic fixation. OSSIO’s fifth product family, OSSIOfiber Compression Staples, allow surgeons to evolve to stronger, bio-integrative compression.
- In September 2022, Olympus Corporation, a medical device company, announced the launch of VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals (HCPs) for endoscopic procedures across multiple medical disciplines. VISERA ELITE III offers various imaging functions, all supported in one system enabling minimally invasive therapies such as Laparoscopic Colectomy and Laparoscopic Cholecystectomy.
- In December 2020, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic, a medical device company, announced the launch of EEA Circular Stapler with Tri-Staple Technology - the first 3-row Circular Stapler with varied height staples. The new Tri-Staple Technology comprises a sloped cartridge face that delivers less stress on tissue. It also offers consistent performance over a broad range of tissue thickness and allows for greater perfusion into the staple line 1,2,3,4,5.
The EEA circular stapler with Tri-Staple technology is designed to work in harmony with the natural properties of the tissue before, during, and after stapling
Business Development Activities by the Market Players
- On July 14, 2023, TELA Bio, Inc., a commercial medical device company, announced a three-year dual-source agreement known biosynthesis to one of the national purchasing groups (GPO). The agreement, which runs through January 1, 2026, provides significant growth opportunities over the term of the contract and provides GPO members with access to significant cost savings and clinical differentiation.
- On January 5, 2023, Organon, a global women’s healthcare company, announced a strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy. The agreement also grants Organon the option to acquire Claria Medical.
- In August 2022, Standard Bariatrics, Inc., a surgical medical device company, announced that they had signed a definitive agreement to be acquired by Teleflex Incorporated, a leading global provider of medical technologies designed to improve the health and quality of people’s lives
U.S.: 
U.K. : 
India : 
